Long-term cost-effectiveness of pharmacist-managed hypertension care in China.

ABSTRACT:

Background

Hypertension is one of the main causes of cardiovascular and kidney diseases in China. However, the rate of effective blood pressure control remains low. Previous studies have shown pharmacist-managed hypertension care can improve treatment outcomes. Nevertheless, the long-term cost-effectiveness of pharmaceutical care has not been fully evaluated in China.

Methods

This study constructed a Markov model to evaluate the cost-effectiveness of pharmacist-managed hypertension care compared with usual care. The model followed a hypothetical patient cohort using 6-month cycles and extended to their life expectancy, adopting a healthcare system perspective. Model parameters were obtained from a randomized controlled trial and published Chinese population data. The primary

SUBMITTER: Wei J 

PROVIDER: S-EPMC12763993 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature